A Dangerous Partnership: Malignancy and Antiphospholipid Antibodies

Jozélio Freire de Carvalho, Lara Ponte Amadei, Carlos Ewerton Maia Rodrigues

Open source

DOI
10.5152/eurasianjmed.2026.261434
Published
2026-07-28
Container
The Eurasian Journal of Medicine
Publisher
AVES YAYINCILIK A.Ş.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5152/eurasianjmed.2026.261434,
  title = {A Dangerous Partnership: Malignancy and Antiphospholipid Antibodies},
  author = {Jozélio Freire de Carvalho and Lara Ponte Amadei and Carlos Ewerton Maia Rodrigues},
  year = {2026},
  journal = {The Eurasian Journal of Medicine},
  doi = {10.5152/eurasianjmed.2026.261434},
  url = {https://doi.org/10.5152/eurasianjmed.2026.261434}
}

RIS

TY  - JOUR
TI  - A Dangerous Partnership: Malignancy and Antiphospholipid Antibodies
AU  - Jozélio Freire de Carvalho
AU  - Lara Ponte Amadei
AU  - Carlos Ewerton Maia Rodrigues
PY  - 2026
JO  - The Eurasian Journal of Medicine
DO  - 10.5152/eurasianjmed.2026.261434
UR  - https://doi.org/10.5152/eurasianjmed.2026.261434
ER  - 

APA

Carvalho, J. F. D., Amadei, L. P., & Rodrigues, C. E. M. (2026). A Dangerous Partnership: Malignancy and Antiphospholipid Antibodies. The Eurasian Journal of Medicine. https://doi.org/10.5152/eurasianjmed.2026.261434

Source records